menu search

Precede Biosciences Unveils Groundbreaking Clinical Data for its Pioneering Liquid Biopsy Platform at ESMO 2023 and Simultaneously Publishes in Nature Medicine

Precede Biosciences Unveils Groundbreaking Clinical Data for its Pioneering Liquid Biopsy Platform at ESMO 2023 and Simultaneously Publishes in Nature Medicine
Pivotal findings stem from Precede’s first-in-class platform in collaboration with Dana-Farber Cancer Institute Results underscore the immense potential of the blood-based platform to impact therapeutic and clinical decision-making Published dataset is largest of its kind, with over 1,200 cell-free-DNA transcriptional profiles from more than 400 patients affected with 15 different cancers BOSTON, Oct. 21, 2023 […] The post Precede Biosciences Unveils Groundbreaking Clinical Data for its Pioneeri... Read More
Posted: Oct 21 2023, 08:25
Author Name: forextv
Views: 092090

Search within

Pages Search Results: